These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 26369126

  • 1. 660 nm Red LED Induces Secretory Leukocyte Protease Inhibitor (SLPI) in Lipopolysaccharide-Stimulated RAW264.7 Cell.
    Jeong SJ, Choi BD, Lee HY, Hwang YH, Kim BH, Cho YI, Yun JJ, Lee BH, Jeong MJ.
    J Nanosci Nanotechnol; 2015 Aug; 15(8):5610-6. PubMed ID: 26369126
    [Abstract] [Full Text] [Related]

  • 2. Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor.
    Jin F, Nathan CF, Radzioch D, Ding A.
    Infect Immun; 1998 Jun; 66(6):2447-52. PubMed ID: 9596701
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function.
    Yang J, Zhu J, Sun D, Ding A.
    Biochim Biophys Acta; 2005 Sep 30; 1745(3):310-7. PubMed ID: 16112212
    [Abstract] [Full Text] [Related]

  • 6. Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure.
    Antoniades CG, Khamri W, Abeles RD, Taams LS, Triantafyllou E, Possamai LA, Bernsmeier C, Mitry RR, O'Brien A, Gilroy D, Goldin R, Heneghan M, Heaton N, Jassem W, Bernal W, Vergani D, Ma Y, Quaglia A, Wendon J, Thursz M.
    Hepatology; 2014 Apr 30; 59(4):1564-76. PubMed ID: 24282114
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of secretory leukocyte protease inhibitor on the tumor necrosis factor-alpha production and NF-kappaB activation of lipopolysaccharide-stimulated macrophages.
    Sano C, Shimizu T, Tomioka H.
    Cytokine; 2003 Jan 07; 21(1):38-42. PubMed ID: 12668158
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines.
    Svensson D, Aidoukovitch A, Anders E, Jönsson D, Nebel D, Nilsson BO.
    Inflamm Res; 2017 Sep 07; 66(9):823-831. PubMed ID: 28597116
    [Abstract] [Full Text] [Related]

  • 11. Secretory leukoprotease inhibitor in mucosal lymph node dendritic cells regulates the threshold for mucosal tolerance.
    Samsom JN, van der Marel AP, van Berkel LA, van Helvoort JM, Simons-Oosterhuis Y, Jansen W, Greuter M, Nelissen RL, Meeuwisse CM, Nieuwenhuis EE, Mebius RE, Kraal G.
    J Immunol; 2007 Nov 15; 179(10):6588-95. PubMed ID: 17982048
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of genes involved in innate responsiveness to bacterial products by differential display.
    Jin F, Nathan C, Ding A.
    Methods; 1998 Dec 15; 16(4):396-406. PubMed ID: 10049647
    [Abstract] [Full Text] [Related]

  • 14. Anti-inflammatory activity of myricetin from Diospyros lotus through suppression of NF-κB and STAT1 activation and Nrf2-mediated HO-1 induction in lipopolysaccharide-stimulated RAW264.7 macrophages.
    Cho BO, Yin HH, Park SH, Byun EB, Ha HY, Jang SI.
    Biosci Biotechnol Biochem; 2016 Aug 15; 80(8):1520-30. PubMed ID: 27068250
    [Abstract] [Full Text] [Related]

  • 15. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide.
    Jin FY, Nathan C, Radzioch D, Ding A.
    Cell; 1997 Feb 07; 88(3):417-26. PubMed ID: 9039268
    [Abstract] [Full Text] [Related]

  • 16. Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice.
    Nakamura A, Mori Y, Hagiwara K, Suzuki T, Sakakibara T, Kikuchi T, Igarashi T, Ebina M, Abe T, Miyazaki J, Takai T, Nukiwa T.
    J Exp Med; 2003 Mar 03; 197(5):669-74. PubMed ID: 12615907
    [Abstract] [Full Text] [Related]

  • 17. Rhododendron album Blume inhibits iNOS and COX-2 expression in LPS-stimulated RAW264.7 cells through the downregulation of NF-κB signaling.
    Park JW, Kwon OK, Kim JH, Oh SR, Kim JH, Paik JH, Marwoto B, Widjhati R, Juniarti F, Irawan D, Ahn KS.
    Int J Mol Med; 2015 Apr 03; 35(4):987-94. PubMed ID: 25784296
    [Abstract] [Full Text] [Related]

  • 18. Suppression of macrophage responses to bacterial lipopolysaccharide by a non-secretory form of secretory leukocyte protease inhibitor.
    Zhu J, Nathan C, Ding A.
    Biochim Biophys Acta; 1999 Sep 21; 1451(2-3):219-23. PubMed ID: 10556576
    [Abstract] [Full Text] [Related]

  • 19. Anti-inflammatory effects of guggulsterone on murine macrophage by inhibiting LPS-induced inflammatory cytokines in NF-κB signaling pathway.
    Zhang JH, Shangguan ZS, Chen C, Zhang HJ, Lin Y.
    Drug Des Devel Ther; 2016 Sep 21; 10():1829-35. PubMed ID: 27330276
    [Abstract] [Full Text] [Related]

  • 20. Stauntoside B inhibits macrophage activation by inhibiting NF-κB and ERK MAPK signalling.
    Liu J, Tang J, Zuo Y, Yu Y, Luo P, Yao X, Dong Y, Wang P, Liu L, Zhou H.
    Pharmacol Res; 2016 Sep 21; 111():303-315. PubMed ID: 27343699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.